AlphAIAlphAI — Financial news for AI agents
aol.comAUG 283 min read$CRDO

Radar AI Stocks Wall Street Is Missing

Camtek reported $600M in orders, 80% tied to advanced packaging, with a 32% upside potential. Astera Labs' Scorpio X entered volume production early, guiding Q3 revenue to $540M-$560M. Credo Technology saw 157% revenue growth, with guidance for 80% growth in fiscal 2027. All three companies are key players in AI infrastructure, with strong fundamentals and growth prospects.

Original reporting
aol.com
Published Aug 28, 2026, 11:45 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 28, 2026, 12:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Radar AI Stocks Wall Street Is Missing — source image
Source · aol.com
Decision brief

The 30-second read

$CRDOBullishMed
01

Why it matters

Earnings beats and forward guidance suggest near‑term upside, but valuation and concentration risks temper enthusiasm.

02

Market read

First‑time earnings and guidance disclosures for three AI‑infrastructure mid‑caps provide fresh trading ideas in the AI supply chain sector.

03

What to watch

Potential geopolitical shipping disruptions for Camtek and valuation compression risk for Astera Labs despite growth.

Relevance 6/10Novelty 7/10Timing: post‑earnings releases August 2026

Background

The article profiles three mid‑cap AI‑infrastructure companies that have recently reported earnings and guidance, positioning them as overlooked beneficiaries of AI capex.

Company-level read

Ticker impact

$CRDOBullishHigh confidence
Context

Credo Technology reported Q4 FY2026 revenue of $437M (+157% YoY) beating consensus and raised FY2027 guidance, indicating strong earnings momentum.

Expected impact

Potential price appreciation toward $334 target if guidance holds.

Evidence & confidence

Revenue beat and margin expansion signal growth; high customer concentration remains a risk.

$ALABBullishHigh confidence
Context

Astera Labs posted Q2 FY2026 revenue of $392.4M (+104% YoY) beating estimates and guided Q3 revenue $540M‑$560M, highlighting rapid growth.

Expected impact

Shares may rally toward $477 target if guidance is credible.

Evidence & confidence

Consistent earnings beats and expanding margins outweigh high valuation multiples.

$CAMTBullishMedium confidence
Context

Camtek delivered Q2 2026 revenue of $133.24M, set $158M‑$160M Q3 guidance and reported $600M+ order backlog extending into 2027.

Expected impact

Potential upside toward $191 target as backlog materializes.

Evidence & confidence

Backlog growth offsets recent GAAP income decline; exposure to Middle East shipping risk noted.

Market effects

Sector

Highlights growing demand for AI‑infrastructure components, supporting broader AI‑related semiconductor sector.

Regional

Mid‑cap US AI supply chain firms may see increased investor interest across North America.

Global

Reinforces the depth of the AI hardware stack beyond headline GPU makers, relevant for global AI capex trends.

Counterpoint

What could challenge this read

High customer concentration and elevated beta could lead to sharper downside if hyperscaler spending slows.

Key entities

  • company
    Credo Technology

    AI connectivity and optical components supplier.

  • company
    Astera Labs

    AI fabric switching and signal conditioning provider.

  • company
    Camtek

    Advanced packaging inspection and HBM solutions.

Read at source← All news

Also covered by

1 outlet

Related articles

SEP 17
$CRDOMed

What's Going On With Credo Technology Stock on Thursday?

Credo Technology (CRDO) shares rose 4% in premarket trading on Thursday. The company launched its 224G-based ZeroFlap optical transceiver family for AI networking, a key step in its roadmap. Credo reported Q1 2027 revenue of $479M, beating estimates, with CEO Bill Brennan highlighting AI infrastructure as a growth driver. Analysts maintain a Buy rating with an average price target of $273.07.

aol.com2 min
SEP 16
$ALABMed

ALAB Stock Holds Support As High Valuation Tests Traders

Astera Labs Inc. (ALAB) stock rose 6.54% due to strong AI infrastructure demand. The company reported $392.4M in quarterly revenue, $153.1M in net income, and $67.2M in free cash flow. ALAB trades at 127x earnings and 37x sales, with a strong balance sheet but high valuation concerns. Traders are watching key price levels around $262–$265 and $272–$275.

stockstotrade.com2 min
SEP 16
$ALABMed

ALAB Broadens Leo Portfolio: Can It Stay Ahead of MRVL & CRDO?

Astera Labs (ALAB) reported record Q2 2026 revenue growth, driven by AI connectivity products. The company expanded its Leo CXL memory controller portfolio, gaining hyperscaler traction. Q3 2026 revenue is expected between $540M and $560M. Competitors Marvell (MRVL) and Credo (CRDO) are also advancing in AI connectivity. ALAB shares rose 51.8% YTD, with a forward P/S of 16.16X.

theglobeandmail.com2 min
SEP 15
$CRDOMedAI 8/10

Credo vs. Broadcom: Which AI Connectivity Stock Is the Better Pick?

Credo (CRDO) and Broadcom (AVGO) are both benefiting from the AI infrastructure boom. Credo reported Q1 revenues of $479M, up 115% YoY, with strong growth in optical and AEC segments. Broadcom saw Q3 revenues of $29.59B, up 85.5% YoY, with AI semiconductors representing 56% of total revenue. Both companies show strong growth but face risks like customer concentration and execution challenges.

finance.yahoo.com2 min
SEP 14
$ALABMed

Why Is Astera Labs Stock Down Today?

Astera Labs (NASDAQ: ALAB) shares dropped 10.1% on Sept. 14, 2026, after AI leaders called for slower AI development, threatening demand for its data-center networking products. The decline was steeper than the S&P 500's 0.3% and Nasdaq's 0.1% drops.

aol.com2 min
SEP 13
$ALABMed

Astera Labs’ Scorpio X Is Already in Volume Production. Citi Showed How Fast the Customer List Is Growing

Astera Labs (ALAB) announced its Scorpio X product line is in volume production and expects revenue growth, with customer engagements increasing. The company guided Q3 revenue to $540M-$560M. Shares dropped after missing S&P 500 inclusion. Analysts set a mid-target price of ~$715, citing potential total return of ~146%. Risks include customer concentration and valuation multiple compression.

tikr.com3 min